← Sites
Mount Halifax Oncology Center
US
PI: Dr. A. Reyes
activated
KRI 0.1
Patients
3
Active (enrolled/consented)
2
Withdrawn
1
Serious AEs
0
Open QA findings
1
Aged data queries
0
Studies & contracts total budget 184000.00 USD
GAL-001: Adaptive Phase II in Refractory Melanoma
Phase II
study active
contract executed
184000 USD
Patients first 3
| Ref | Status | Consented | Study |
|---|---|---|---|
| GAL001-001 | enrolled | 2026-04-30 | GAL-001: Adaptive Phase II in Refractory Melanoma |
| GAL001-002 | enrolled | 2026-05-26 | GAL-001: Adaptive Phase II in Refractory Melanoma |
| GAL001-003 | withdrawn | 2026-05-13 | GAL-001: Adaptive Phase II in Refractory Melanoma |
Luna participants (2)
Safety 1 AEs · 0 serious
No serious adverse events at this site.
QA findings 1 open
open
major
Protocol deviation
DOSE MODIFICATION ERROR: Dose held longer than protocol-permitted 6 weeks.
Monitoring visits (0)
No visits recorded.
Payments (1)
23500 USD
pending_review
due 2026-09-17